BioSpace News Archive

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that it approved equity awards to David Marek in connection with his previously-announced employment by Myovant Sciences, Inc. as its chief executive officer, which consisted of restricted stock units to acquire 223,076 common shares of Myovant Sciences Ltd., and an option to purchase 306,427 Myovant common shares.

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17th, before the market opens

This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patients and severe acute watery diarrhea

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, today announced that it will release financial results for the second quarter of fiscal year 2021 ended December 31, 2020, before the market open on Tuesday, February 2, 2021

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the submission of an Investigational New Drug (IND) to FDA for the investigational use of Tempol for the treatment of Coronavirus (COVID-19). The submission of the IND to FDA followed a Pre-IND meeting with FDA in which FDA gave specific recommendations on Chemistry, Manufacturing and Controls (CMC) and Clinical aspects to be included in the IND. The Company plans to se

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2020 results on Wednesday, February 24, 2021 at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its fourth quarter and full-year 2020 results prior to the call. A live audiocast of the conference call will be available on the Investor Relat

Clinical trials software provider Teckro announces growth of its executive team to build on 2020’s momentum that includes more than 19,800 sites globally reliant on Teckro and the expansion of its digital engagement platform to give site staff real-time communication with study experts.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, announced a partnership with the Rotary Club of Chinatown to enable businesses operating in Manhattan’s Chinatown neighborhood to conduct weekly COVID-19 monitoring of their staff using its pioneering SalivaClear COVID-19 pooled saliva testing platform.

James Lanthier, CEO of Mindset, commented, “Mindset is thrilled to present at KCSA’s conference.

New Website, RMAadagency.com, Provides Overview of Services and Quick Reference for Clinical Research Organizations in Need of Advertising Assistance